ADA Technologies has received a grant of $149,000 from the National Cancer Institute (NCI) to research and develop nanotechnology imaging and sensing platforms.
ADA's research involves developing a nano-enabled sensing platform for analyzing biomolecules, such as cancer biomarkers, that offers greater sensitivity than existing technologies.
Analysis platforms that provide high sensitivity and high throughput are essential to detecting cancer biomarkers, according to the Littleton, CO-based company. These elements are designed to facilitate cancer screening and improve the diagnostic process.
Copyright © 2008 AuntMinnie.com
